# Altammune Inc. — Form D

Altammune Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2011-01-26. The offering totals $50K, of which $46K was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2011-01-26
- Form: D
- Accession: 0001511092-11-000002
- Industry: Other Health Care
- Exemptions: 06
- Total offering: $50K
- Amount sold: $46K
- Remaining: $4K
- Investors: 7
- Date of first sale: 2011-01-15
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-154403

## Issuer

- Name: Altammune Inc.
- CIK: 0001511092
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 639 ANNESLIE ROAD, BALTIMORE, MD, 21212
- Phone: 410-929-5544

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Adam Kaplin | Director | Baltimore, MD |
| Mark Worthington | Director | Baltimore, MD |
| Adam Kaplin | Executive Officer | Baltimore, MD |
| Mark Worthington | Executive Officer | Baltimore, MD |

## More

- [CIK 1511092 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1511092&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001511092-11-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.